doi: 10.1128/AAC.18.3.471.
Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro
- PMID: 7425614
- PMCID: PMC284024
- DOI: 10.1128/AAC.18.3.471
Item in Clipboard
Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro
Antimicrob Agents Chemother.
1980 Sep.
Abstract
Granulocyte progenitor cells were grown with acyclovir to study potential marrow toxicity. Concentrations of up to 220 microM had little effect on progenitor cell growth.
Similar articles
-
Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.Antimicrob Agents Chemother. 1987 Mar;31(3):452-4. doi: 10.1128/AAC.31.3.452. Antimicrob Agents Chemother. 1987. PMID: 3495235 Free PMC article.
-
Effect of acyclovir and interferon on human hematopoietic progenitor cells.Antimicrob Agents Chemother. 1982 Jan;21(1):146-50. doi: 10.1128/AAC.21.1.146. Antimicrob Agents Chemother. 1982. PMID: 6177284 Free PMC article.
-
Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells.Antiviral Res. 1996 Mar;29(2-3):261-7. doi: 10.1016/0166-3542(95)00905-1. Antiviral Res. 1996. PMID: 8739604
-
Preclinical toxicology profile of acyclovir: an overview.Am J Med. 1982 Jul 20;73(1A):27-30. doi: 10.1016/0002-9343(82)90058-4. Am J Med. 1982. PMID: 7048916 Review. No abstract available.
-
In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs.Cell Biol Toxicol. 2001;17(2):95-105. doi: 10.1023/a:1010958121396. Cell Biol Toxicol. 2001. PMID: 11499700 Review.
Cited by
-
Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.J Virol. 2013 Jan;87(2):779-89. doi: 10.1128/JVI.02427-12. Epub 2012 Oct 31. J Virol. 2013. PMID: 23115277 Free PMC article.
-
In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.Antimicrob Agents Chemother. 1996 Feb;40(2):514-9. doi: 10.1128/AAC.40.2.514. Antimicrob Agents Chemother. 1996. PMID: 8834914 Free PMC article.
-
Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.Antimicrob Agents Chemother. 1987 Mar;31(3):452-4. doi: 10.1128/AAC.31.3.452. Antimicrob Agents Chemother. 1987. PMID: 3495235 Free PMC article.
-
Acyclovir prophylaxis for herpes simplex virus infection.Antimicrob Agents Chemother. 1987 Mar;31(3):361-7. doi: 10.1128/AAC.31.3.361. Antimicrob Agents Chemother. 1987. PMID: 3555331 Free PMC article. Review.
-
Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.Antimicrob Agents Chemother. 1994 Jul;38(7):1534-40. doi: 10.1128/AAC.38.7.1534. Antimicrob Agents Chemother. 1994. PMID: 7979285 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
